Back to today’s briefing

Story perspectives

New Therapy Targets Pediatric Brain Cancer Stem Cells

3/13/2025

43 4

Summary

Story summary

A groundbreaking study from Emory University and QIMR Berghofer Medical Research Institute has unveiled that CT-179 effectively targets cancer stem cells in pediatric brain tumors. This innovative therapy holds great promise for treating medulloblastoma and other brain cancers, offering hope for improved survival rates and a better quality of life for young patients. Clinical trials are on the horizon.

1 of 1

Story summary

A groundbreaking study from Emory University and QIMR Berghofer Medical Research Institute has unveiled that CT-179 effectively targets cancer stem cells in pediatric brain tumors. This innovative therapy holds great promise for treating medulloblastoma and other brain cancers, offering hope for improved survival rates and a better quality of life for young patients. Clinical trials are on the horizon.